Nanoparticulate Drug Delivery to Colorectal Cancer: Formulation Strategies and Surface Engineering

Author(s): Thao Truong-Dinh Tran, Phuong Ha-Lien Tran, Yichao Wang, Puwang Li, Lingxue Kong

Journal Name: Current Pharmaceutical Design

Volume 22 , Issue 19 , 2016

Become EABM
Become Reviewer


The evolution of polymer-based nanoparticle as a drug delivery carrier has greatly contributed to the development of advanced nano and micro-medicine in the past few decades. The polymer-based nanoparticles of biodegradable and biocompatible polymers such as poly (lactide-co-glycolide) and chitosan which have been approved by Food & Drug Administration and/or European Medicine Agency can particularly facilitate the maintaining of specific properties for a real transition from laboratory to the clinical oral and parental administration. This review presents an overview of the strategies of preparing polymeric nanoparticles and using them for targeting colorectal cancer. Theranostics and surface engineering aspects of nanoparticle design in colonic cancer delivery are also highlighted.

Keywords: Nanoparticles, poly (lactide-co-glycolide), chitosan, colorectal cancer, theranostic, surface engineering.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Page: [2904 - 2912]
Pages: 9
DOI: 10.2174/1381612822666160217140932
Price: $65

Article Metrics

PDF: 36
PRC: 1